Early Stage Partners provides early stage venture capital financing to the Midwest’s most promising entrepreneurial companies in:

  • Technology
  • Life Sciences
  • Advanced Materials
  • Instruments, Controls & Electronics
  • Cleantech

 

 

Mission

Mission

Early Stage Partners was formed in 2001 with the belief that the Midwest would create and attract a significant number of companies that would be attractive early stage venture capital investments.

Since then, that belief has been borne out. The Midwest is in the midst of a surge of entrepreneurial energy that is generating high quality technologies and companies. We are pleased to work with the region’s leading entrepreneurs to provide financing, advice, and access to value-added networks.

With a track record of successful investing, ESP is now investing from Fund II.

Find Out More About ESP

News & Events

Reverse Medical Sells Neurovascular Guide Catheter Business

January 23, 2012
Proceeds will help fund other thrombectomy and neurovascular technologies.

CytoPherx Raises $34 Million Early Stage Venture Capital Round

January 04, 2012
Early Stage Partners, Onset Ventures and Capital Midwest Fund Co-Lead Funding for Company Focused on Addressing Acute Kidney Injury

Amplifinity Raises Series A Early Stage Venture Capital Round

December 05, 2011
Amplifinity, a leading Word of Mouth marketing company, will expand customer acquisition and technology development.

Cost of Waiting For Service Calls is $37.7 Billion Annually

November 01, 2011
It costs the American economy $37.7 billion to wait for service deliveries each year, according to TOA Technologies' Third Annual Cost of Waiting Survey.